<code id='556ED0375C'></code><style id='556ED0375C'></style>
    • <acronym id='556ED0375C'></acronym>
      <center id='556ED0375C'><center id='556ED0375C'><tfoot id='556ED0375C'></tfoot></center><abbr id='556ED0375C'><dir id='556ED0375C'><tfoot id='556ED0375C'></tfoot><noframes id='556ED0375C'>

    • <optgroup id='556ED0375C'><strike id='556ED0375C'><sup id='556ED0375C'></sup></strike><code id='556ED0375C'></code></optgroup>
        1. <b id='556ED0375C'><label id='556ED0375C'><select id='556ED0375C'><dt id='556ED0375C'><span id='556ED0375C'></span></dt></select></label></b><u id='556ED0375C'></u>
          <i id='556ED0375C'><strike id='556ED0375C'><tt id='556ED0375C'><pre id='556ED0375C'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:8291
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          JPM 2024: Verve Therapeutics looks to mainstream genome editing
          JPM 2024: Verve Therapeutics looks to mainstream genome editing

          VerveTherapeuticsCEOSekarKathiresanVerveSANFRANCISCO—Thepromiseofgenomeeditinghasgivenrisetopotentia

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          'The Exorcist' director William Friedkin dead at 87

          1:29DirectorWilliamFriedkinposesforportrait,July01,2019inMilan.RosdianaCiaravolo/GettyImages,FILEWil